secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001641489-25-000030
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics posts May 2025 investor presentation on website
----------------------------------------------------------------

- Presentation posted on May 16, 2025 for use in investor and analyst meetings.
- Slide deck highlights the company's focus on type 1 diabetes.
- No new financial or clinical data were disclosed in the presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000030/0001641489-25-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000030/vtvt-20250516.htm
  HTML page:      https://secwatch.observer/filing/0001641489-25-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer